Director – Global Insights
Revolution Medicines
Director – Global Insights
Revolution Medicines
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting directly to the Senior Director, Global Insights, the Director, Global Insights role requires strategic thinking and expertise to provide critical contributions to disease area strategy, life-cycle planning and product and portfolio decisions. The individual in this role will be responsible for conducting market research in a variety of geographies to help support the development and potential commercialization of the RevMed portfolio and will be an influential voice in developing asset strategy. The ideal candidate will have experience working on pipeline molecules in Oncology across multiple geographies, strong problem-solving skills, a strategic mindset, and will exhibit curiosity, flexibility, and be comfortable with ambiguity.
This position would ideally be based at our headquarters in Redwood City, CA., however open to remote candidates who are willing to travel to our CA office on a regular basis.
Responsibilities include:
Works cross functionally to develop and execute the global insights roadmap in support of current business needs and future opportunities across the portfolio of targeted oncology molecules.
Translates insights into strategic recommendations to inform and influence global business decision making.
Communicates strategic insights from market research to drive critical business decisions and strategy.
Initiates and facilitates activities that enhance organizational knowledge regarding the relevant market and potential product attributes, usage, market dynamics, and competition.
Communicates and aligns key internal stakeholders around market research and analytics objectives and outputs including qualifying the results based on the strength of the data and identifying limitations.
Develops and presents actionable recommendations to key stakeholders, focusing on key findings and relevant implications to each stakeholder group, and senior leadership.
Researches, analyzes, and formulates insights on complex markets, various disease states, competitive landscapes, and relevant market and managed care dynamics.
Synthesizes and communicates the similarities, differences, and considerations necessary to inform Global clinical development plans.
Participates in cross-functional teams to gather input for functional activities and ensures alignment.
Partners closely with other Insights and Analytics functions at the Global and Regional level (Market Research, Data Analytics, Competitive Intelligence).
Works closely with Global Commercial Development, Clinical Development, Portfolio Management, and Medical Affairs to support early-stage decision making.
Maintains an in-depth understanding of Revolution Medicines’ diverse product offerings, competitive positioning, and the broader market dynamics shaping the industry's future.
Reinforces market research best practices, identify market research and data sources, vendor options, and methodologies that are best suited to address a business need. Manages third parties associated with this function.
Serves as a resource to identify and tracking key business drivers.
Required Skills, Experience and Education:
Bachelor's degree required (MBA preferred) with 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role with 6+ years of experience in a strategic analytics role.
Experience supporting pipeline and portfolio decision making.
Extensive primary research and secondary analytical skills required; ability to translate the data and learning into actionable recommendations for business growth.
Experience conducting and coordinating of market research in regions outside the U.S.
Track record of being a collaborative team player, and adaptive to meet the needs of a growing business.
Strong problem solver with experience leveraging a variety of research and analytical vendors, study designs, and building quality research vendor partnerships.
Demonstrated ability to influence senior management and key business partners.
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
Ability to represent Revolution Medicines well with internal and external stakeholders, including strong interpersonal skills including verbal and written communication.
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients.
Preferred Skills:
Experience with targeted oncolytics.
Demonstrated ability to synthesize complex information and influence decision-making at the executive level.
Proven experience in a smaller, rapidly growing, company.
#LI-Remote #LI-JW1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Base Pay Salary Range 201000 - 251000 USD
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.
Explore more opportunities at Revolution Medicines